Earnings growth for S&P 500 firms is now projected to be 7.7% compared to the previous year, which would represent the lowest ...

The best stocks to buy over the next three months are chosen based on hedge fund sentiment toward these investments. For this ...

We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Recent developments and advancements in AI may have been overshadowed by tariff updates in recent months. Undoubtedly, Trump ...

Amid the ongoing volatility, the pullback in several stocks with strong fundamentals presents a lucrative opportunity to ...

But recent short-term worries about the economy as well as specific worries raised about the development timeline for AI, and more specifically quantum computing, sparked a pullback for some of these ...

CoreWeave's IPO debuted at $40 per share, raising $1.5 billion, which is down a billion from the initial goal. Check out our ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

AI cloud firm CoreWeave's first day on public markets was a dud, but experts warn against drawing conclusion about the health ...

We recently published a list of 14 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where GE Vernova Inc. (NYSE:GEV) stands against other AI news and ...

CoreWeave’s IPO exposes AI’s uncertain boom, billion-dollar debts, and fragile growth, hinting at a possible industry bubble.

Genetics-testing company 23andMe Holding Co. (ME) merged in 2021 with a SPAC formed by British billionaire magnate Richard Branson. The deal was valued at $3.5 billion, and the company said it had a ...